Feature CytoDyn developing leronlimab (PRO140) as a pipeline in a drug CytoDyn (OTCQB:CYDY), which is in the process of filing for FDA approval for leronlimab (PRO140) in treatment-experienced HIV patients, is continuing to develop its lead drug candidate in eight metastatic solid tumors... September 17, 2019